For as long as cardiovascular disease (CVD) prevention has been advocated, and guidance
recommendations for clinicians based on the synthesis of existing evidence provided
by international guidelines,[
[1]
] the benefits of healthy lifestyles have been emphasised. However, compared to the
substantial and closely quantifiable benefits of therapeutic interventions, especially
supported smoking cessation, blood pressure and lipid lowering medications, recommendations
around lifestyle changes have been largely generic comments and essentially statements
of ‘common-sense’.- Piepoli M.F.
- Hoes A.W.
- Agewall S.
- Albus C.
- Brotons C.
- Catapano A.L.
- Cooney M.T.
- Corrà U.
- Cosyns B.
- Deaton C.
- Graham I.
- Hall M.S.
- Hobbs F.D.R.
- Løchen M.L.
- Löllgen H.
- Marques-Vidal P.
- Perk J.
- Prescott E.
- Redon J.
- Richter D.J.
- Sattar N.
- Smulders Y.
- Tiberi M.
- van der Worp H.B.
- van Dis I.
- Verschuren W.M.M.
- Binno S.
ESC scientific document group. European guidelines on cardiovascular disease prevention
in clinical practice: the sixth joint task force of the European society of cardiology
and other societies on cardiovascular disease prevention in clinical practice (constituted
by representatives of 10 societies and by invited experts) developed with the special
contribution of the European association for cardiovascular prevention & rehabilitation
(EACPR).
Eur Heart J. 2016; 2016: 2315
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- ESC scientific document group. European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR).Eur Heart J. 2016; 2016: 2315
- Never enough recommended. Beyond the AHA/ACC guideline on lifestyle and behavior for cardiovascular prevention.Eur J Inter Med. 2020; 70: 8-9
- Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts.N. Engl. J. Med. 2018; 378
- How does exercise treatment compare with antihypertensive medications? A net-work meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.Br J Sports Med. 2019; 53: 859-869
- Mortality reduction with physical activity in patients with and without cardiovascular disease.Eur Heart J. 2019; 40: 3547-3555
- EUROASPIRE investigators. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European society of cardiology esc-eorp euroaspire V registry.Eur J Prev Cardiol. 2019; 26: 824-835
Article info
Publication history
Published online: June 20, 2020
Accepted:
May 14,
2020
Received:
May 11,
2020
Identification
Copyright
© 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
